Patents by Inventor ASTEX THERAPEUTICS

ASTEX THERAPEUTICS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical Compounds
    Publication number: 20130210820
    Abstract: The invention provides a compound of the formula (1): or a salt, solvate, N-oxide or tautomer thereof.
    Type: Application
    Filed: January 30, 2013
    Publication date: August 15, 2013
    Applicant: ASTEX THERAPEUTICS LIMITED
    Inventor: ASTEX THERAPEUTICS LIMITED
  • PYRROLOPYRIMIDINE COMPOUNDS AND THEIR USES
    Publication number: 20130184285
    Abstract: The disclosed compounds relate to treatments and therapies for protein kinase-associated disorders. There is also a need for compounds useful in the treatment or prevention or amelioration of one or more symptoms of cancer, transplant rejections, and autoimmune diseases. Furthermore, there is a need for methods for modulating the activity of protein kinases, such as CDK1, CDK2, CDK4, CDK5, CDK6, CDK7, CDK8 and CDK9, using the compounds provided herein.
    Type: Application
    Filed: March 6, 2013
    Publication date: July 18, 2013
    Applicants: ASTEX THERAPEUTICS, NOVARTIS AG
    Inventors: NOVARTIS AG, ASTEX THERAPEUTICS